Atellica® CH Diazo Direct Bilirubin (D_DBil)— 510(k) K223078
Substantially EquivalentSiemens Healthcare Diagnostics, Inc.
FDA 510(k) clearance K223078 for Atellica® CH Diazo Direct Bilirubin (D_DBil), Substantially Equivalent on 2023-06-12. Applicant: Siemens Healthcare Diagnostics, Inc.. Device class: 2.
Clearance details
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Product code
- Code CIG
- Device class
- Class 2
- Regulation
- 21 CFR 862.1110
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Newark, DE, US
Recent devices under product code CIG
view allMore clearances from Siemens Healthcare Diagnostics, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.